Remedy Mid Tier
CVE-2017-17678
MEDIUM
Severity by source
AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N
Primary rating from NVD · only source for this CVE.
CVSS VectorNVD
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N
Lifecycle Timeline
1DescriptionNVD
BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS). A DOM-based cross-site scripting vulnerability was discovered in a legacy utility.
AnalysisAI
BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS). Rated medium severity (CVSS 6.1), this vulnerability is remotely exploitable, no authentication required, low attack complexity. No vendor patch available.
Technical ContextAI
This vulnerability is classified as Cross-Site Scripting (XSS) (CWE-79), which allows attackers to inject malicious scripts into web pages viewed by other users. BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS). A DOM-based cross-site scripting vulnerability was discovered in a legacy utility. Affected products include: Bmc Remedy Mid-Tier.
RemediationAI
No vendor patch is available at time of analysis. Monitor vendor advisories for updates. Sanitize all user input, use Content-Security-Policy headers, encode output contextually (HTML, JS, URL). Use frameworks with built-in XSS protection.
More in Remedy Mid Tier
View allBMC Remedy Mid Tier 9.1SP3 is affected by remote and local file inclusion. Rated critical severity (CVSS 9.8), this vuln
**UNSUPPORTED WHEN ASSIGNED** An issue was discovered in BMC Remedy Mid Tier 7.6.04. Rated critical severity (CVSS 9.8),
BMC Remedy 9.1SP3 is affected by authenticated code execution. Rated high severity (CVSS 8.8), this vulnerability is rem
BMC Remedy Mid Tier 9.1SP3 is affected by log hijacking. Rated medium severity (CVSS 5.3), this vulnerability is remotel
An issue was discovered in BMC Remedy Mid Tier 7.6.04. Rated medium severity (CVSS 4.2), this vulnerability is remotely
Same weakness CWE-79 – Cross-site Scripting (XSS)
View allShare
External POC / Exploit Code
Leaving vuln.today